ResearcherUniversity of GlasgowActive in the last 2 years
Daniel Schreyer
Matched on ORCID iD 0000-0002-9788-0168; OpenAlex author ID A5029383759. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 30
2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 1 paper
Papers 4
- MYC ecDNA promotes intratumour heterogeneity and plasticity in PDAC. Co-author DOI 10.1038/s41586-025-08721-9↗
- A microfluidic-based PDAC organoid system reveals the impact of hypoxia in response to treatment. First author DOI 10.1038/s41420-023-01334-z↗
- CDK7 inhibition augments response to multidrug chemotherapy in pancreatic cancer. Co-author DOI 10.1186/s13046-022-02443-w↗
- Deconstructing Pancreatic Cancer Using Next Generation-Omic Technologies-From Discovery to Knowledge-Guided Platforms for Better Patient Management. Co-author DOI 10.3389/fcell.2021.795735↗
Closest collaborators
The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Christian P. Pilarsky · 3 shared papers, 2022–2025 · strength 0.51
- Paper A microfluidic-based PDAC organoid system reveals the impact of hypoxia in response to treatment. DOI 10.1038/s41420-023-01334-z↗
- Paper MYC ecDNA promotes intratumour heterogeneity and plasticity in PDAC. DOI 10.1038/s41586-025-08721-9↗
- Paper CDK7 inhibition augments response to multidrug chemotherapy in pancreatic cancer. DOI 10.1186/s13046-022-02443-w↗
- Peter J. Bailey · 3 shared papers, 2021–2025 · strength 0.48
- Paper Deconstructing Pancreatic Cancer Using Next Generation-Omic Technologies-From Discovery to Knowledge-Guided Platforms f… DOI 10.3389/fcell.2021.795735↗
- Paper MYC ecDNA promotes intratumour heterogeneity and plasticity in PDAC. DOI 10.1038/s41586-025-08721-9↗
- Paper CDK7 inhibition augments response to multidrug chemotherapy in pancreatic cancer. DOI 10.1186/s13046-022-02443-w↗
- Marlene Geyer · 1 shared paper, 2023 · strength 0.22
- Karla C. S. Queiroz · 1 shared paper, 2023 · strength 0.22
- Simon T. Barry · 1 shared paper, 2021 · strength 0.19
- John P. Neoptolemos · 1 shared paper, 2021 · strength 0.19
- Francesca Lupo · 1 shared paper, 2025 · strength 0.17
- Giuseppe Malleo · 1 shared paper, 2025 · strength 0.17
- Vincenzo Corbo · 1 shared paper, 2025 · strength 0.17
- Antonio Agostini · 1 shared paper, 2025 · strength 0.17
- Antonia Malinova · 1 shared paper, 2025 · strength 0.17
- Sabrina L. D’Agosto · 1 shared paper, 2025 · strength 0.17
- Rita Teresa Lawlor · 1 shared paper, 2025 · strength 0.17
- Lisa Veghini · 1 shared paper, 2025 · strength 0.17
- Elena Fiorini · 1 shared paper, 2025 · strength 0.17
- Claudio Luchini · 1 shared paper, 2025 · strength 0.17
- Michèle Milella · 1 shared paper, 2025 · strength 0.17
- Carmine Carbone · 1 shared paper, 2025 · strength 0.17
- David Arthur Tuveson · 1 shared paper, 2025 · strength 0.17
- Aldo Scarpa · 1 shared paper, 2025 · strength 0.17
- Roberto Salvia · 1 shared paper, 2025 · strength 0.17
- Hai Yang · 1 shared paper, 2022 · strength 0.13
- Bin Lan · 1 shared paper, 2022 · strength 0.13
- Nathalie Britzen‐Laurent · 1 shared paper, 2022 · strength 0.13
- Siyuan Zeng · 1 shared paper, 2022 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.